IP Group PLC
LSE:IPO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
IP Group PLC
Intangible Assets
IP Group PLC
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IP Group PLC
LSE:IPO
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Intangible Assets
$2.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Schroders PLC
LSE:SDR
|
Intangible Assets
£441.2m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
N
|
Ninety One PLC
LSE:N91
|
Intangible Assets
£23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Allfunds Group PLC
AEX:ALLFG
|
Intangible Assets
€956.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
IP Group PLC
Glance View
IP Group Plc engages in commercializing intellectual properties mainly from its partner universities. The firm's segments include University partnership business and Venture capital fund management. The University partnership business segment is engaged in the commercialization of intellectual property through the formation of long-term partner relationships with universities. The Venture capital fund management segment is engaged in the management of venture funds focusing on the United Kingdom's early-stage technology companies and the provision of corporate finance advice. The firm's life sciences portfolio comprises holdings in approximately 38 companies. Its technology portfolio comprises holdings in approximately 44 companies. The company has three areas of geographic focus, which includes the United Kingdom, the United States, Australia and New Zealand.
